Syros Pharmaceuticals Board of Directors, Key People and Executives

Health Care & Life Sciences » Biotechnology | Syros Pharmaceuticals Inc.

Syros Pharmaceuticals Inc. | Key People and Executives

Peter Wirth

Chairman

Nancy A. Simonian

President, Chief Executive Officer & Director

Michael W. Bonney

Director

Srinivas Akkaraju

Independent Director

Peter Wirth

Chairman

Nancy A. Simonian

President, Chief Executive Officer & Director

Joseph J. Ferra

Chief Financial Officer

Eric R. Olson

Chief Scientific Officer

David A. Roth

Chief Medical Officer

Gerald E. Quirk

Chief Legal & Administrative Officer

Jeremy P. Springhorn

Chief Business Officer

Christian C. Fritz

Vice President-Biology

Michael W. Bonney

Director

Naomi Aoki

Head-Media Relations

Srinivas Akkaraju

Independent Director

Richard A. Young

Independent Director

Amir H. Nashat

Independent Director

Marsha H. Fanucci

Independent Director

Vicki L. Sato

Independent Director

Phillip A. Sharp

Independent Director

View Profile

Address	620 Memorial Drive Cambridge Massachusetts 02139 United States
Employees	-
Website	http://www.syros.com
Updated	07/08/2019
Syros Pharmaceuticals, Inc. engages in the development of novel gene control therapies for cancer and other diseases. It has developed a proprietary platform that is designed to systematically and efficiently analyze unexploited region of DNA in human disease tissue to identify and drug novel targets linked to genomically defined patient populations. The company focuses on developing treatments for cancer and immune mediated diseases and is building a pipeline of gene control medicines.